GENZYME CORP Net Change in Cash
GENZYME CORP reported Net Change in Cash of $597.32 million for the 12-month period ending 2010-12-31, per its 10-K filed 2011-03-01.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2011-03-01
- GENZYME CORP cash and cash equivalents, period increase (decrease) for the quarter ending 2010-12-31 was $440.40M, a 602.54% increase year-over-year.
- GENZYME CORP cash and cash equivalents, period increase (decrease) for the quarter ending 2010-09-30 was $217.36M.
- GENZYME CORP cash and cash equivalents, period increase (decrease) for the quarter ending 2010-06-30 was $38.47M, a 56.53% decline year-over-year.
- GENZYME CORP cash and cash equivalents, period increase (decrease) for the quarter ending 2010-03-31 was -$98.91M, a 238.66% decline year-over-year.
- GENZYME CORP cash and cash equivalents, period increase (decrease) for fiscal 2010 was $597.32M, a 251.08% increase from fiscal 2009.
- GENZYME CORP cash and cash equivalents, period increase (decrease) for fiscal 2009 was $170.14M.
- GENZYME CORP cash and cash equivalents, period increase (decrease) for fiscal 2008 was -$294.91M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2010-12-31 | $440.40M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | $657.76M derived: sum of 2 quarters · filed 2011-03-01 | $696.23M derived: sum of 3 quarters · filed 2011-03-01 | $597.32M 10-K · filed 2011-03-01 |
| 2010-09-30 | $217.36M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-11-09 | $255.83M derived: sum of 2 quarters · filed 2010-11-09 | $156.92M 10-Q · filed 2010-11-09 | $219.61M derived: sum of 4 quarters · filed 2011-03-01 |
| 2010-06-30 | $38.47M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2010-09-07 | -$60.44M 10-Q/A · filed 2010-09-07 | $2.25M derived: sum of 3 quarters · filed 2011-03-01 | -$50.12M derived: sum of 4 quarters · filed 2011-03-01 |
| 2010-03-31 | -$98.91M 10-Q/A · filed 2010-05-11 | -$36.22M derived: sum of 2 quarters · filed 2011-03-01 | -$88.59M derived: sum of 3 quarters · filed 2011-03-01 | -$101.00K derived: sum of 4 quarters · filed 2011-03-01 |
| 2009-12-31 | $62.69M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | $10.32M derived: sum of 2 quarters · filed 2011-03-01 | $98.81M derived: sum of 3 quarters · filed 2011-03-01 | $170.14M 10-K · filed 2011-03-01 |
| 2009-09-30 | -$52.37M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-11-09 | $36.12M derived: sum of 2 quarters · filed 2010-11-09 | $107.45M 10-Q · filed 2010-11-09 | -$239.18M derived: sum of 4 quarters · filed 2011-03-01 |
| 2009-06-30 | $88.49M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2010-09-07 | $159.82M 10-Q/A · filed 2010-09-07 | -$186.81M derived: sum of 3 quarters · filed 2011-03-01 | $38.24M derived: sum of 4 quarters · filed 2011-03-01 |
| 2009-03-31 | $71.33M 10-Q/A · filed 2010-05-11 | -$275.30M derived: sum of 2 quarters · filed 2011-03-01 | -$50.25M derived: sum of 3 quarters · filed 2011-03-01 | |
| 2008-12-31 | -$346.63M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | -$121.58M derived: sum of 2 quarters · filed 2011-03-01 | -$294.91M 10-K · filed 2011-03-01 | |
| 2008-09-30 | $225.05M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2009-11-02 | $51.72M 10-Q · filed 2009-11-02 | ||
| 2008-06-30 | -$173.32M 10-Q/A · filed 2009-09-04 | |||
| 2007-12-31 | $374.84M 8-K · filed 2010-06-14 |